Resultados de la búsqueda 161-170 of 12382 for 搜索引擎原理咨询邮箱：lgooxc@hotmail.com

1. Cirugía - Ensayos clínicos - Mayo Clinic

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Potentially Resectable Pancreatic Cancer - No involvement of the celiac artery, common hepatic artery, and superior mesenteric artery (SMA) and, if present, ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

6. Centros vasculares - Ensayos clínicos - Mayo Clinic

   We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Jacksonville, Fla. The purpose of this study is to evaluate the safety and feasibility of the spinal array in treatment of patients with leptomeningeal ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to show how well lenalidomide and dexamethasone work with or without daratumumab in treating patients with high-risk smoldering ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...